Related Experiment Videos
Ethylmalonic encephalopathy-report of two cases
Lada Cindro Heberle1, Asma A Al Tawari, Dina G Ramadan
1Pediatric Neurology Unit, NBK, Al Sabah Hospital, Safat 4078, C.N. 13041, Kuwait. heberlelada@hotmail.com
Brain & Development
|December 27, 2005
Summary
Ethylmalonic encephalopathy, a rare metabolic disorder, is caused by ETHE1 gene mutations. This study reports two new cases, including a novel mutation, highlighting the disease's genetic basis and clinical spectrum.
Area of Science:
- Biochemistry
- Genetics
- Pediatric Neurology
Background:
- Ethylmalonic encephalopathy is a rare, autosomal recessive metabolic disorder.
- It presents in infancy with developmental delay, acrocyanosis, petechiae, chronic diarrhea, and often early death.
- Biochemical hallmarks include urinary organic acid abnormalities and are linked to mutations in the ETHE1 gene.
Observation:
- Two additional cases of ethylmalonic encephalopathy are presented.
- The first patient exhibited typical symptoms, atypical clinical features, and extensive neuroimaging changes.
- The second patient presented with typical clinical and biochemical profiles, alongside cytochrome C oxidase deficiency.
Findings:
- A novel homozygous mutation in exon 3 of the ETHE1 gene was identified in the first patient.
- The genetic basis of the second patient was not investigated but clinical and biochemical findings were consistent.
- These cases expand the known spectrum of ETHE1 gene mutations and clinical presentations.
Implications:
- Understanding ETHE1 gene mutations is crucial for diagnosing ethylmalonic encephalopathy.
- The findings contribute to the limited knowledge of this rare metabolic disease.
- Further research may elucidate genotype-phenotype correlations and potential therapeutic targets.
Related Concept Videos
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...